L, M. A., O, J., & T, L. L. (2019). THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB. Journal of the ASEAN Federation of Endocrine Societies, 34, 17. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/4149